Cancer: Clinical trials unite mice and humans

Nature

Volumn 483, Issue 7391, 2012, Pages 546-548

  Johnson, Leisa ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LKB1; SELUMETINIB;

CANCER; DRUG DEVELOPMENT; MUTATION; RESEARCH WORK; RODENT;

ADD ON THERAPY; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; GENE MUTATION; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; LUNG NON SMALL CELL CANCER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE K RAS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SHORT SURVEY; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE;

ANIMALS; BENZIMIDAZOLES; CLINICAL TRIALS, PHASE II AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; LUNG NEOPLASMS; PHARMACOGENETICS; TAXOIDS;

MUS;

EID: 84859208169     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/483546a     Document Type: Short Survey

References (11)

1. Chen, Z. et al. Nature 483, 613-617 (2012).
2. Douillard, J. Y. et al. J. Clin. Oncol. 28, 744-752 (2010).
3. Mascaux, C. et al. Br. J. Cancer 92, 131-139 (2005).
4. Ji, H. et al. Cancer Res. 67, 4933-4939 (2007).
5. Hoeflich, K. P. et al. Cancer Res. 72, 210-219 (2012).
6. Jackson, E. L. et al. Cancer Res. 65, 10280-10288 (2005).
7. Singh, M. et al. Nature Biotechnol. 28, 585-593 (2010).
8. Ji, H. et al. Nature 448, 807-810 (2007).
9. Berghmans, T. et al. Thorac. Oncol. 3, 6-12 (2008).
10. Erasmus, J. J., Rohren, E. & Swisher, S. G. Proc. Am. Thorac. Soc. 6, 171-179 (2009).
11. Kola, I. & Landis, J. Nature Rev. Drug Discov. 3, 711-716 (2004).